drugset / Trial / NCT02099916

Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF

NCT02099916

RandomizedParallel-groupSingle-blindTreatment

Summary

Poor responders to ovarian stimulation represents one of the most frustrating problems in reproductive medicine. The investigators hypothesize that ovarian response of those patients could improve by treating these patients with 25 mg DHEA tid for 12 weeks prior to stimulation.

Timeline

Start
2014-10
Primary completion
2014-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator DHEA Unknown 25 mg Oral
Comparator Gonal Unknown
Comparator Menopur Protein / enzyme biologic

Indications